1. Home
  2. EDSA vs GXAI Comparison

EDSA vs GXAI Comparison

Compare EDSA & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • GXAI
  • Stock Information
  • Founded
  • EDSA 2015
  • GXAI 2021
  • Country
  • EDSA Canada
  • GXAI United States
  • Employees
  • EDSA N/A
  • GXAI N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • GXAI
  • Sector
  • EDSA Health Care
  • GXAI
  • Exchange
  • EDSA Nasdaq
  • GXAI Nasdaq
  • Market Cap
  • EDSA 6.2M
  • GXAI 7.3M
  • IPO Year
  • EDSA N/A
  • GXAI 2023
  • Fundamental
  • Price
  • EDSA $2.03
  • GXAI $1.32
  • Analyst Decision
  • EDSA Strong Buy
  • GXAI
  • Analyst Count
  • EDSA 1
  • GXAI 0
  • Target Price
  • EDSA $21.00
  • GXAI N/A
  • AVG Volume (30 Days)
  • EDSA 14.5K
  • GXAI 97.7K
  • Earning Date
  • EDSA 05-14-2025
  • GXAI 05-27-2025
  • Dividend Yield
  • EDSA N/A
  • GXAI N/A
  • EPS Growth
  • EDSA N/A
  • GXAI N/A
  • EPS
  • EDSA N/A
  • GXAI N/A
  • Revenue
  • EDSA N/A
  • GXAI $27,740.00
  • Revenue This Year
  • EDSA N/A
  • GXAI N/A
  • Revenue Next Year
  • EDSA N/A
  • GXAI N/A
  • P/E Ratio
  • EDSA N/A
  • GXAI N/A
  • Revenue Growth
  • EDSA N/A
  • GXAI 1473.05
  • 52 Week Low
  • EDSA $1.55
  • GXAI $1.00
  • 52 Week High
  • EDSA $5.59
  • GXAI $7.50
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 36.85
  • GXAI 60.39
  • Support Level
  • EDSA $1.99
  • GXAI $1.07
  • Resistance Level
  • EDSA $2.14
  • GXAI $1.44
  • Average True Range (ATR)
  • EDSA 0.11
  • GXAI 0.08
  • MACD
  • EDSA -0.03
  • GXAI 0.03
  • Stochastic Oscillator
  • EDSA 21.28
  • GXAI 67.57

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

Share on Social Networks: